Jimmy is a 68-year-old retired kindergarten teacher. Whenever he can, he volunteers to read to children during story time at the local library. He was first diagnosed with low-grade non-muscle-invasive bladder cancer (NMIBC) 12 years ago. Since then, he has had two...
Watch the presentation of Dr. Félix Guerrero Ramos (Madrid, Spain) The virtual 1st International Workshop in Urothelial Carcinoma took place on the 7th and 14th of October 2021 and was organized by the University Hospital La Paz, IdiPAZ and Grupo Centro de Tumores...
Cystoscopy* has a high sensitivity for detecting carcinoma in situ (CIS) in non-muscle-invasive bladder cancer (NMIBC). Therefore, it can accurately rule out this high-grade and aggressive tumour. Submit your answer and read the opinion of Dr. Joost Boormans...
Reviewed by Mr. Hugh Mostafid “As EpiCheck® results are remarkable, this assay is now included in the diagnostic work-up of UTUC at our center.” [1] Urothelial carcinomas are most commonly found in the bladder, in which case they are referred to as bladder cancer....
Reviewed by Professor Jørgen Bjerggaard Jensen (Aarhus University Hospital, Aarhus, Denmark) “A strategy alternating the urine marker Bladder EpiCheck® with cystoscopy in the surveillance of patients with low-grade intermediate-risk bladder cancer is cost-equivalent...
Urinary biomarkers: Are we prepared to replace cystoscopies? Watch the webinar presentations by Dr. Fernando Lozano and Dr. Alberto Breda On June 7, 2021, HM Hospitales (Spain) organised the webinar “Frequently asked questions in the management of urothelial cancer”....
David is a 71-year-old amateur golfer. Despite the closing of the golf club due to the COVID-19 pandemic, he enjoys playing a game in his 8 square meter garden using a miniature golf set. He was diagnosed with non-muscle-invasive bladder cancer (NMIBC) 3.5 years ago....
Which biomarker metric is dependent on disease prevalence, and therefore cannot be compared between different cohorts? Submit your answer and read the opinion of Mr. Hugh Mostafid. A) Sensitivity B) NPV* * negative predictive value C) Specificity...
May is Bladder Cancer Awareness Month. We need you to create awareness! The World Bladder Cancer Patient Coalition hosts this special month to highlight the facts about bladder cancer, promote awareness of the disease and call for more investment in research,...
Reviewed by Morgan Rouprêt, Professor at the AP-HP Sorbonne University in the Academic Urology Department of the Pitié-Salpêtrière Hospital, Paris, France. Prof. Rouprêt is a panel member of the European Guidelines for non-muscle invasive bladder cancer (NMIBC)....
